Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
$1.49
-4.2%
$0.79
$0.26
$16.50
$16.69M1.21961,250 shs6,215 shs
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
$5.67
$3.42
$12.72
$54.38M2.55132,982 shs36,800 shs
FONAR Co. stock logo
FONR
FONAR
$16.49
+1.8%
$21.01
$12.13
$24.05
$104.38M1.1218,746 shs1,269 shs
Movano Inc. stock logo
MOVE
Movano
$0.47
-4.1%
$0.52
$0.37
$1.50
$25.81M0.3565,225 shs69,887 shs
Yubo International Biotech Limited stock logo
YBGJ
Yubo International Biotech
$0.95
$0.67
$0.07
$1.04
$112.27M5.49875 shsN/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
+10.28%+41.36%+188.50%-36.27%-88.13%
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
0.00%0.00%0.00%0.00%0.00%
FONAR Co. stock logo
FONR
FONAR
-3.63%-3.74%-27.29%-16.97%+1.00%
Movano Inc. stock logo
MOVE
Movano
-4.75%-5.88%+14.95%-30.52%-57.36%
Yubo International Biotech Limited stock logo
YBGJ
Yubo International Biotech
0.00%0.00%0.00%+216.67%+968.62%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
N/AN/AN/AN/AN/AN/AN/AN/A
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/AN/AN/AN/AN/A
Movano Inc. stock logo
MOVE
Movano
N/AN/AN/AN/AN/AN/AN/AN/A
Yubo International Biotech Limited stock logo
YBGJ
Yubo International Biotech
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
N/AN/AN/AN/A
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
N/AN/AN/AN/A
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/A
Movano Inc. stock logo
MOVE
Movano
N/AN/AN/AN/A
Yubo International Biotech Limited stock logo
YBGJ
Yubo International Biotech
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
$20K834.40N/AN/A($0.33) per share-4.52
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
$3.38M0.00N/AN/A$4.80 per share0.00
FONAR Co. stock logo
FONR
FONAR
$98.64M1.06$2.73 per share6.05$23.07 per share0.71
Movano Inc. stock logo
MOVE
Movano
N/AN/AN/AN/A$0.06 per shareN/A
Yubo International Biotech Limited stock logo
YBGJ
Yubo International Biotech
$610K184.05N/AN/A($0.02) per share-47.50

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
-$29.04M-$4.80N/AN/AN/A-8,129.09%-820.34%5/20/2024 (Estimated)
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
-$8.92MN/A0.00N/AN/AN/A-13.58%-13.02%N/A
FONAR Co. stock logo
FONR
FONAR
$9.38M$1.848.96N/A12.63%8.47%6.45%5/20/2024 (Estimated)
Movano Inc. stock logo
MOVE
Movano
-$29.28M-$0.65N/AN/AN/A-361.91%-215.55%5/20/2024 (Estimated)
Yubo International Biotech Limited stock logo
YBGJ
Yubo International Biotech
-$1.20MN/A0.00N/A-196.21%N/A-62.52%N/A

Latest MOVE, EYES, YBGJ, BSGM, and FONR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/14/2024Q2 2024
FONAR Co. stock logo
FONR
FONAR
N/A$0.54+$0.54$0.54N/A$25.39 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
N/AN/AN/AN/AN/A
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
N/AN/AN/AN/AN/A
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/AN/A
Movano Inc. stock logo
MOVE
Movano
N/AN/AN/AN/AN/A
Yubo International Biotech Limited stock logo
YBGJ
Yubo International Biotech
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
N/A
0.12
0.12
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
N/A
22.15
22.15
FONAR Co. stock logo
FONR
FONAR
N/A
9.35
9.15
Movano Inc. stock logo
MOVE
Movano
N/A
1.44
1.26
Yubo International Biotech Limited stock logo
YBGJ
Yubo International Biotech
N/A
0.21
0.15

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
7.16%
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
N/A
FONAR Co. stock logo
FONR
FONAR
50.64%
Movano Inc. stock logo
MOVE
Movano
16.64%
Yubo International Biotech Limited stock logo
YBGJ
Yubo International Biotech
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
411.20 million10.16 millionOptionable
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
1513.14 million6.94 millionOptionable
FONAR Co. stock logo
FONR
FONAR
5616.33 million6.19 millionNot Optionable
Movano Inc. stock logo
MOVE
Movano
3455.04 million50.31 millionNot Optionable
Yubo International Biotech Limited stock logo
YBGJ
Yubo International Biotech
20118.18 million51.43 millionNot Optionable

MOVE, EYES, YBGJ, BSGM, and FONR Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

BioSig Technologies logo

BioSig Technologies

NASDAQ:BSGM
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Second Sight Medical Products logo

Second Sight Medical Products

NASDAQ:EYES
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.
FONAR logo

FONAR

NASDAQ:FONR
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.
Movano logo

Movano

NASDAQ:MOVE
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It also develops System-on-a-Chip (SoC), for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
Yubo International Biotech logo

Yubo International Biotech

OTCMKTS:YBGJ
Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.